Merck wins patent fight on Zetia, Vytorin; Fitch warns of ‘pure pharma’ risks;

 @FiercePharma: Oral drugs don't work well in kids with obesity-related Type 2 diabetes. Their disease is hard to treat, period--NYT. Article | Follow @FiercePharma > A U.S…
Read the full story: News